UK first to approve CRISPR treatment for diseases: what you need to know

You can also search for this author in PubMed Google Scholar The landmark decision could transform the treatment of sickle-cell disease and β-thalassaemia — but the technology is expensive. In a world first, the UK medicines regulator has approved a therapy that uses CRISPR gene editing as a…

#pubmedgooglescholar #kaydavies #universityofoxford #uksciencemediacentre #nature #healthcare #boston #massachusetts #crisprtherapeutics #zug